title: [Fully possible to reduce the costs of hypertension treatment].
authors: Läkemedelscentrum, Stockholms läns landsting.
authors: Björn
authors: B
authors: Wettermark
authors: Anna
authors: A
authors: Angman
authors: Paul
authors: P
authors: Hjemdahl
mesh_terms: D047228:Angiotensin II Type 1 Receptor Blockers / Q000008:administration & dosage / Q000191:economics; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000008:administration & dosage / Q000191:economics; D000959:Antihypertensive Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000191:economics*; D002121:Calcium Channel Blockers / Q000008:administration & dosage / Q000191:economics; D017046:Cost Savings; D003362:Cost-Benefit Analysis; D004232:Diuretics / Q000008:administration & dosage / Q000191:economics; D016527:Drug Costs; D006801:Humans; D006973:Hypertension / Q000188:drug therapy / Q000191:economics*; D017063:Outcome Assessment, Health Care; D010818:Practice Patterns, Physicians' / Q000191:economics; D013548:Sweden
chemical_list: D047228:Angiotensin II Type 1 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D002121:Calcium Channel Blockers; D004232:Diuretics